Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Authors' reply to letter: He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome.
Mullish BH, Michael DR, Dabcheva M, Webberley TS, Coates N, John DA, Wang D, Luo Y, Plummer SF, Marchesi JR. Mullish BH, et al. Among authors: marchesi jr. Neurogastroenterol Motil. 2024 Aug;36(8):e14820. doi: 10.1111/nmo.14820. Epub 2024 May 19. Neurogastroenterol Motil. 2024. PMID: 38764218 No abstract available.
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.
Payne T, Appleby M, Buckley E, van Gelder LMA, Mullish BH, Sassani M, Dunning MJ, Hernandez D, Scholz SW, McNeill A, Libri V, Moll S, Marchesi JR, Taylor R, Su L, Mazzà C, Jenkins TM, Foltynie T, Bandmann O. Payne T, et al. Among authors: marchesi jr. Mov Disord. 2023 Aug;38(8):1493-1502. doi: 10.1002/mds.29450. Epub 2023 May 29. Mov Disord. 2023. PMID: 37246815 Free PMC article. Clinical Trial.
Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites.
Yip AYG, King OG, Omelchenko O, Kurkimat S, Horrocks V, Mostyn P, Danckert N, Ghani R, Satta G, Jauneikaite E, Davies FJ, Clarke TB, Mullish BH, Marchesi JR, McDonald JAK. Yip AYG, et al. Among authors: marchesi jr. Nat Commun. 2023 Aug 22;14(1):5094. doi: 10.1038/s41467-023-40872-z. Nat Commun. 2023. PMID: 37607936 Free PMC article.
A double-blind, randomized, placebo-controlled study assessing the impact of probiotic supplementation on the symptoms of irritable bowel syndrome in females.
Mullish BH, Michael DR, Dabcheva M, Webberley TS, Coates N, John DA, Wang D, Luo Y, Plummer SF, Marchesi JR. Mullish BH, et al. Among authors: marchesi jr. Neurogastroenterol Motil. 2024 Apr;36(4):e14751. doi: 10.1111/nmo.14751. Epub 2024 Jan 29. Neurogastroenterol Motil. 2024. PMID: 38287443 Clinical Trial.
Diverse Phenotypes, Consistent Treatment: A Study of 30 997 South Asian and White Inflammatory Bowel Disease Patients Using the UK Inflammatory Bowel Disease BioResource.
Balarajah S, Martinez-Gili L, Alexander JL, Mullish BH, Perry RW, Li JV, Marchesi JR, Parkes M, Orchard TR, Hicks LC, Williams HRT. Balarajah S, et al. Among authors: marchesi jr. J Crohns Colitis. 2025 Jan 11;19(1):jjae186. doi: 10.1093/ecco-jcc/jjae186. J Crohns Colitis. 2025. PMID: 39657589 Free PMC article.
Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures.
Quraishi MN, Cheesbrough J, Rimmer P, Mullish BH, Sharma N, Efstathiou E, Acharjee A, Gkoutus G, Patel A, Marchesi JR, Camuzeaux S, Chappell K, Valdivia-Garcia MA, Ferguson J, Brookes M, Walmsley M, Rossiter A, van Schaik W, McInnes RS, Cooney R, Trauner M, Beggs A, Iqbal T, Trivedi PJ. Quraishi MN, et al. Among authors: marchesi jr. J Crohns Colitis. 2024 Dec 14:jjae189. doi: 10.1093/ecco-jcc/jjae189. Online ahead of print. J Crohns Colitis. 2024. PMID: 39673746
243 results